Full text is available at the source.
DeepDrugDiscovery finds substances that boost cell cleaning and can cross into the brain for Alzheimer's disease
Updated
Abstract
Essence
DeepDrugDiscovery prioritized brain-penetrant, mTOR-independent autophagy enhancers that improved Alzheimer's disease model phenotypes.
Evidence
A platform and preclinical validation study combined AI screening with worm and mouse Alzheimer's disease model tests of two lead compounds for blood-brain barrier crossing, aggregate clearance, and memory restoration.
Caveat
The evidence remains from computational screening plus animal disease models, not human clinical testing of efficacy, dosing, or safety.
Simplified
Longevity & Aging